# 89Zr-atezolizumab PET Scan and Lobular Breast Cancer

> **NCT04222426** · NA · TERMINATED · sponsor: **University Medical Center Groningen** · enrollment: 1 (actual)

## Conditions studied

- Lobular Metastatic Breast Cancer

## Interventions

- **OTHER:** 89Zr-atezolizumab PET scans

## Key facts

- **NCT ID:** NCT04222426
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-18
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-05-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Cessation of main trial of which this study was a biomarker imaging side study.
- **Last updated:** 2022-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04222426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04222426, "89Zr-atezolizumab PET Scan and Lobular Breast Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04222426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*